Hemostemix Inc., of Calgary, Alberta, appointed David Wood chair of its board, Bryson Goodwin CEO, Thomas Smeenk president and Natasha Sever chief financial officer. It also named Yari Nieken to its board.
Lantern Pharma Inc., of Dallas, appointed Franklyn Prendergast and Vijay Chandru to its board.
Mateon Therapeutics Inc., of Agoura Hills, Calif., appointed Steven King prospective CEO of Edgepoint AI.
PMV Pharmaceuticals Inc., of Cranbury, N.J., appointed Leila Alland chief medical officer.